Loading
IARC estimates 14,703 new cancer cases and 9,428 cancer deaths in Haiti in 2024; the commonest new cancers are prostate, breast and colorectum. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Prostate | 2,146 | 70.8 | Prostate cancer |
| Breast | 1,952 | 38.9 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 1,136 | 13.4 | Colorectal cancer |
| Cervix uteri | 1,091 | 21.5 | Cervical cancer |
| Stomach | 1,089 | 12.3 | Gastric & gastro-oesophageal junction cancer |
| Liver and intrahepatic bile ducts | 937 | 10.6 | Hepatocellular carcinoma |
| Trachea, bronchus and lung | 782 | 9.2 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Leukaemia | 478 | 4.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Ovary | 408 | 7.3 | Ovarian cancer |
| Pancreas | 340 | 4.0 | Pancreatic ductal adenocarcinoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Prostate | 1,343 | 44.3 | Prostate cancer |
| Breast | 880 | 18.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 864 | 9.9 | Hepatocellular carcinoma |
| Stomach | 828 | 9.8 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 705 | 8.4 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 680 | 8.5 | Colorectal cancer |
| Cervix uteri | 659 | 13.0 | Cervical cancer |
| Pancreas | 320 | 3.8 | Pancreatic ductal adenocarcinoma |
| Leukaemia | 282 | 3.0 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Oesophagus | 202 | 2.3 | Oesophageal cancer |
No trial record in OnCo lists a site in Haiti. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Haiti.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Haiti is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Haiti is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.